HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

A C W Zannettino Selected Research

Preleukemia

10/2015Hypoxia inducible factor (HIF)-2α accelerates disease progression in mouse models of leukemia and lymphoma but is not a poor prognosis factor in human AML.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


A C W Zannettino Research Topics

Disease

1Lymphoma (Lymphomas)
10/2015
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2015
1Myeloid Leukemia (Leukemia, Myelocytic)
10/2015
1Preleukemia
10/2015
1Anoxia (Hypoxia)
10/2011
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
04/2010
1Osteosarcoma (Osteogenic Sarcoma)
10/2002

Drug/Important Bio-Agent (IBA)

1Messenger RNA (mRNA)IBA
10/2015
1Complementary DNA (cDNA)IBA
10/2015
1OxygenIBA
10/2011
1imatinib (Gleevec)FDA Link
04/2010
1Organic Cation Transporter 1IBA
04/2010
1Caspase 3 (Caspase-3)IBA
10/2002
1Cisplatin (Platino)FDA LinkGeneric
10/2002
1Doxorubicin (Adriamycin)FDA LinkGeneric
10/2002

Therapy/Procedure

1Transplantation (Transplant Recipients)
10/2015